相关实验视频

Updated: Sep 13, 2025

Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation

Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation

Published on: October 20, 2022

预测早产期内尼菲迪平的反应:一个风险得分,包括ABCG2多态和临床因素

Jungsun Kim¹, Ji Min Han², Jeong Yee³

¹College of Pharmacy, Kangwon National University, Chuncheon, Republic of Korea.

Pharmacogenomics

|August 1, 2025

概括

这项研究开发了一个使用ABCG2基因变异的风险评分系统,以预测早产孕妇的尼菲迪平治疗失败. 该系统有助于识别不太可能对尼菲迪平反应的患者,以提供个性化的护理.

科学领域:

药物基因组学药物基因组学
产科产科产科产科产科
医学遗传学医学遗传学

背景情况:

尼菲迪平是一种毒解剂,是ATP结合带超级家族G成员2 (ABCG2) 的基质.
ABCG2遗传变异可能会影响尼菲迪平在管理早产的疗效.
对早产需要个性化治疗策略.

研究的目的:

开发基于ABCG2多形态和临床因素的风险评分系统,以预测尼菲迪平治疗失败.
探索ABCG2基因变异与孕妇尼菲迪平治疗反应之间的关联.

主要方法:

在ABCG2基因中分析了8种单核酸多态 (SNP).
多变量分析被用来计算调整的赔率比率 (AOR).
使用独立风险因子的AOR构建了一个风险评分系统,以预测治疗失败.

主要成果:

母亲年龄≥33岁,频繁收缩 (间隔<4分钟) 和高收缩强度 (≥20 mmHg) 是治疗失败的临床风险因素.
ABCG2 多态 rs2622604 和 rs4148157 与治疗失败的风险分别增加了 8.6 倍和 4.3 倍.
风险评分有效预测治疗失败,预测风险为2.8%至93.9%,得分为0至9.

结论:

结合ABCG2多态和临床因素的新型风险评分系统可以预测尼菲迪平治疗失败.
这个系统可以帮助临床医生识别那些对尼菲迪平反应可能性较低的患者.
评分系统支持针对早产管理的个性化护理策略.

关键词:

这就是ABCG2ABCG2.药物不良事件是药物不良事件.尼菲迪平因 (nifedipine) 是一种尼菲迪平因 (nifedipine) 的一种药物.多形态主义的多态主义.过早产生的劳动.

更多相关视频

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

相关概念视频

Adrenergic Antagonists: ɑ and β-Receptor Blockers

Adrenergic Antagonists: ɑ and β-Receptor Blockers

Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...

Factors Affecting Drug Response: Overview

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...

Factors Influencing Drug Absorption: Presystemic Elimination

Factors Influencing Drug Absorption: Presystemic Elimination

The pharmacokinetic journey of oral drugs begins with a crucial first pass through the hepatic portal system, called the first-pass effect. This first pass significantly impacts bioavailability — the proportion of a drug that enters systemic circulation and is available for therapeutic action. The primary route sees the drug absorbed by intestinal membranes and then shunted to the liver via the hepatic portal vein. Here, pre-systemic elimination occurs as drugs face metabolism or biliary...